GRIDD is a world-class research facility, offering unique resources and drawing on a global network of partners to target the world’s most devastating diseases.

GRIDD is a Griffith University research institute with a focus on early stage and pre-clinical drug discovery. GRIDD’s aim is to utilise its unique resources, dedicated researchers and international partnerships to drive the discovery and development of revolutionary new treatments to improve human health.

We are currently focusing on a number of key discovery areas, including cancer, infectious diseases, Parkinson’s disease, drug resistance and spinal cord injury repair. Innovating at the cutting-edge of both chemistry and biology, we collaborate with governments, academia, industry and communities to create knowledge that transforms lives.

GRIDD is home to two significant resources in Compounds Australia and NatureBank. Compounds Australia is the nations’ industry standard compound curation facility, unmatched in the Southern hemisphere and a leader globally. NatureBank is Australia’s largest collection of raw biota, processed into large extract and fraction libraries. Both resources are available to researchers and industry worldwide that, like GRIDD, are seeking to discover new treatments and cures for debilitating illnesses.

Join us

Join us in the search for treatments for the world's most devastating diseases

Unique Resources

Explore our unrivalled resources available for use

NatureBank

Access NatureBank’s collection of 60,000 natural product fractions ready for screening against any disease.

Discover more

Compounds Australia

Australia's only dedicated compound management facility, Compounds Australia connects chemists and biologists for drug discovery research.

Learn more

Key technologies

Our key technologies include high-throughput screening, Fourier transform mass spectrometry and fragment-based screening.

Discover more

GRIDD flyer

Download

Compounds Australia flyer

Download

NatureBank flyer

Download

Research Highlights

Australian of the Year 2017

Professor Emeritus Alan Mackay-Sim

Alan Mackay-Sim is a world-renowned trailblazer in cell transplantation, who paved the way for innovative research to repair damaged spinal cords to return the gift of movement to paralysed people.

Drug resistance

Director Professor Jenny Martin, who was elected to the Australian Academy of Science in May 2017, talks about her research into the rapidly growing problem of antibiotic resistance.

Directions in drug discovery

Delve deeper into our research and find out more about our approaches, innovation and collaborations across key research areas:

Cancer

An estimated 130,470 new cases of cancer were diagnosed in Australia in 2016, with that number set to rise to 150,000 by 2020. Professors Vicky Avery, Sally-Ann Poulsen and Associate Professor Rohan Davis are working to discover compounds that are active against breast, prostate and pancreatic cancer.

Discover more

Infectious diseases

Infectious diseases kill more than one million people annually. GRIDD Professors Kathy Andrews, Vicky Avery and Ronald Quinn are seeking new drugs to treat diseases like malaria and TB, while Director Professor Jenny Martin is exploring new approaches to treat complicated urinary tract infections as well as melioidosis, a common disease in northern Australia.

Discover more

Parkinson’s disease

About 70,000 Australians are affected by this progressive disease of the nervous system. Professor George Mellick’s research explores the genetics of Parkinsonism and the interactions between genetic and environmental factors that contribute to onset and development of the disease.

Discover more

Drug resistance

Professor Sally-Ann Poulsen has discovered a new way to reverse multidrug resistance in cancer, while Director Professor Jenny Martin is exploring how to disarm bacteria so they cannot cause disease.

Discover more

Spinal cord injury repair

Up to half a million people globally suffer from spinal cord injury. GRIDD’s Associate Professor James St John in the Clem Jones Centre for Neurobiology and Stem Cell Research offers hope of new therapies. The 2017 Australian of the Year, Professor Emeritus Alan Mackay-Sim pioneered this research.

Discover more

Our researchers

See the team who make up GRIDD and find out more about our individual research strengths.

Discover more

Stay up to date

Connect with us

Want to know more?

Get in touch with GRIDD